You are subscribed to the Drug Topics Issue Alert.

Drug Topics Issue Alert eNewsletter Subscribe
Print/Digital Edition Subscribe

March 19, 2016

To view this email as a web page, click here  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

CHECK OUT OUR LATEST ISSUE

The 2016 Drug Pipeline

An impressive lineup of new products is pouring into the market, and many other up-and-comers are right behind. » More

Part 2: The pharmacist's role in managing opioid use disorder

The goal of this program is to provide knowledge and awareness of the safety, efficacy, and legal status of the opioid overdose antagonist naloxone. » More

Reformulate, remonetize — and let the patient beware

We all know there exists an entire sub-industry of incredibly overpriced pharmaceutical products that contribute nothing to the advancement of medicine. » More

Related Articles

Drug Topics through the decades: 1920-1930

Pharmacy automation: Our silent partner in success

An advocate for change urges pharmacists to speak out

 

Downloads

Drug Topics App - Download

Drug Topics Digital Edition - Download

You are subscribed to the Drug Topics Issue Alert.

 

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us